BioNTech
NEWS
The companies intend to push the vaccine candidate into human trials by April of this year, subject to regulatory approval.
“This acquisition fits with our strategy to expand our capabilities and build our presence in the U.S. and further strengthens our immunotherapy pipeline,” said Ugur Sahin, co-founder and chief executive officer of BioNTech.
Pharma companies add new members to executive ranks and boards of directors.
Companies from across the globe provide updates on their business and product pipelines.
This makes it one of the biggest single private funding rounds for a biotechnology company in European history.
Biotech and pharma companies from across Europe and Asia share company and pipeline updates.
Four biotech companies began trading on the Nasdaq this morning. Here’s a look at today’s launches and one rumored IPO.
Companies from across the globe provide updates to their pipelines and businesses, with news from BioNTech, Mologic, Akcea, RedHill, and more.
In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.
JOBS
IN THE PRESS